Shelton Capital Management Medpace Holdings, Inc. Transaction History

Shelton Capital Management

  • $3.43 Billion
  • Q1 2024

A detailed history of Shelton Capital Management transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Shelton Capital Management holds 1,017 shares of MEDP stock, worth $412,535. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,017
Previous 1,017 -0.0%
Holding current value
$412,535
Previous $311,000 32.15%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$227.52 - $312.68 $29,805 - $40,961
-131 Reduced 11.41%
1,017 $311,000
Q3 2023

Nov 14, 2023
SELL
$233.98 - $281.67 $21,760 - $26,195
-93 Reduced 7.49%
1,148 $277,000
Q2 2023

Aug 10, 2023
SELL
$187.26 - $240.17 $10,673 - $13,689
-57 Reduced 4.39%
1,241 $298,000
Q1 2023

May 11, 2023
BUY
$174.31 - $239.52 $2,266 - $3,113
13 Added 1.01%
1,298 $244,000
Q4 2022

Feb 13, 2023
SELL
$153.06 - $226.57 $19,897 - $29,454
-130 Reduced 9.19%
1,285 $272,000
Q3 2022

Nov 14, 2022
SELL
$145.13 - $182.49 $16,544 - $20,803
-114 Reduced 7.46%
1,415 $222,000
Q1 2021

May 14, 2021
BUY
$132.02 - $168.26 $201,858 - $257,269
1,529 New
1,529 $251,000
Q4 2020

Feb 16, 2021
SELL
$109.38 - $149.19 $205,415 - $280,178
-1,878 Closed
0 $0
Q3 2020

Nov 09, 2020
BUY
$92.95 - $130.61 $174,560 - $245,285
1,878 New
1,878 $210,000
Q1 2020

May 13, 2020
SELL
$61.71 - $101.95 $149,708 - $247,330
-2,426 Closed
0 $0
Q4 2019

Feb 11, 2020
SELL
$70.08 - $84.64 $11,843 - $14,304
-169 Reduced 6.51%
2,426 $204,000
Q3 2019

Nov 13, 2019
BUY
$62.38 - $85.89 $161,876 - $222,884
2,595 New
2,595 $218,000

Others Institutions Holding MEDP

# of Institutions
622
Shares Held
25.1M
Call Options Held
154K
Put Options Held
117K
View Full List

About Medpace Holdings, Inc.

MEDP Quotes by TradingView
  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $12.6B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Shelton Capital Management Portfolio

Follow Shelton Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Shelton Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email